This webinar will provide a summary of the additional medicare reporting requirements under the Sunshine Act rules, and tips for assuring compliance to protect both the manufacturers of FDA regulated products and physicians.
This webinar will summarize the new medicare reporting requirements and provide practical solutions to most common situations that are prevalent and necessary between life-science product manufacturers and physicians. Templates for reporting format, acceptable accounting practices, exemptions to reporting requirements, and time-lines for compliance and enforcement will be discussed.
Why Should You Attend:
The Sunshine Act exposes the physicians and manufacturers to new reporting requirements which are unprecedented in their scope and detail. Non-compliance to these requirements would lead to hefty fines. The new rules, which will be enforced by the Center for Medicare and Medicaid Services (CMS) starting August 2013, would require new accounting practices and disclosures by both the manufactures and physicians.This webinar will summarize the new medicare reporting requirements and provide practical solutions to most common situations that are prevalent and necessary between life-science product manufacturers and physicians. Templates for reporting format, acceptable accounting practices, exemptions to reporting requirements, and time-lines for compliance and enforcement will be discussed.
Areas Covered in the Webinar:
- The provision and rationale for the Sunshine Act, 2010 and CMS’s Final Rule.
- Definitions of covered products and covered entities.
- Kind of payments covered and exempted for reporting to CMS
- Format of reporting to CMS
- Dealing with CMS’s inquiries regarding reported information.
- Acceptable and Unacceptable practices
- Comparison of Federal reporting requirements with Industry best practices.
- Legal and practical implications of reporting financial information for manufacturers and physicians.
- Regulatory solutions for most common anticipated issues with reporting.
Who Will Benefit:
This webinar will provide valuable information to:- Physicians and other prescribers of medical products
- Manufacturers of FDA regulated products: Drug, Medical Device and Biotech Companies
- Financial analysts and investors, venture capitalists, insurance professionals
- Legal experts involved in assisting physicians and patients alike with medical malpractice
- Medical accounting companies
- Senior management for companies developing new products for US market
- Regulatory affairs professionals, research analysts
Course Provider
Mukesh Kumar,
